Loading clinical trials...
Loading clinical trials...
This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy, postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses of MF101 for 4 weeks....
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bionovo
NCT07218445 · Obesity, Menopause Hot Flashes
NCT07238478 · Joint Discomfort, Joint Pain, Stiffness, Function, and more
NCT07022925 · Perimenopause, Perimenopausal Depression, and more
NCT06864520 · Climacteric Symptoms, Hot Flashes
NCT06716554 · Menopause, Hot Flashes, and more
Alta Bates, Jordan Research and Education Institute (REDI)
Berkeley, California
Clinical Trials Research
Lincoln, California
Northern California Research
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions